# The LNK adaptor protein: a dual regulator of proliferation and migration in solid tumors

**Authors:** Jessica C. Mantilla-Ollarves, Laura Velazquez, Leticia Rocha-Zavaleta

PMC · DOI: 10.1080/23723556.2026.2644701 · Molecular & Cellular Oncology · 2026-03-16

## TL;DR

This review explores how the LNK protein can both prevent and promote cancer growth in different solid tumors.

## Contribution

The paper highlights LNK's dual role in regulating cancer cell proliferation and migration in solid tumors.

## Key findings

- LNK inhibits proliferation and migration in some solid tumors.
- LNK activates proliferation and migration in other types of solid tumors.
- LNK's function contrasts with its role in hematological malignancies.

## Abstract

Cancer is a significant public health problem. Alterations in critical cellular responses, such as proliferation, survival, and migration, are hallmarks of cancer. Deregulation of the JAK/STAT, MAPK, and PI3K/AKT signaling pathways has been implicated in the development of most solid cancers; therefore, their strict control is a primary research focus. The LNK adaptor protein is a key negative regulator of these pathways in normal cells and in certain hematological malignancies, where it regulates the proliferation, migration, and inflammatory response of different cell types. However, the function of LNK in solid tumors is less clear. Recent evidence suggests that LNK inhibits proliferation and migration in some types of solid tumors but activates these same processes in others. In this review, we provide an overview of the essential functions of LNK in healthy tissues, compare these functions with LNK’s reported activities in solid tumors, and discuss the potential mechanisms involved in the dual actions of the LNK protein.

## Linked entities

- **Genes:** SH2B3 (SH2B adaptor protein 3) [NCBI Gene 10019]
- **Proteins:** SH2B3 (SH2B adaptor protein 3)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, SH2B3 (SH2B adaptor protein 3) [NCBI Gene 10019] {aka IDDM20, LNK}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}
- **Diseases:** Cancer (MESH:D009369), inflammatory (MESH:D007249), hematological malignancies (MESH:D019337)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12997970/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12997970/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC12997970/full.md

---
Source: https://tomesphere.com/paper/PMC12997970